MAP — Microba Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- AU$24.16m
- AU$20.32m
- AU$14.76m
Annual cashflow statement for Microba Life Sciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.85 | 3.53 | 7.36 | 6.99 | 3.34 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.4 | -12.4 | -15.6 | -12 | -12.4 |
| Capital Expenditures | -1.87 | -3.04 | -4.38 | -2.9 | -3.91 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.14 | 0.038 | -9.57 | 0.066 | 0.103 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.73 | -3 | -13.9 | -2.83 | -3.8 |
| Financing Cash Flow Items | -1.9 | -0.596 | -1.26 | -0.385 | -0.715 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29.2 | 16.7 | 18.4 | 5.58 | 12.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.6 | 1.46 | -11.2 | -9.15 | -3.79 |